Germantown, TNNCT07629206Now EnrollingIRB Ready

Low-Risk, Early Stage Breast Cancer Clinical Trial in Germantown, TN

Access cutting-edge low-risk, early stage breast cancer treatment through this clinical trial at a research site in Germantown. Study-provided care at no cost to qualified participants.

Sponsored by IceCure Medical Ltd.

Quick Self-Assessment

See if you qualify for this Germantown location

Preparing your pre-screening questionsā€¦

Expert Care in Germantown

Access low-risk, early stage breast cancer specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related low-risk, early stage breast cancer treatment provided free

Apply for This Germantown Location

Check if you qualify for this low-risk, early stage breast cancer clinical trial in Germantown, TN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Germantown

    Convenient for TN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Germantown site if eligible
  4. 4Begin participation

About This Low-Risk, Early Stage Breast Cancer Study in Germantown

The FDA has granted marketing authorization for the ProSenseĀ® Cryoablation System for the local treatment of patients aged 70 years or older with low-risk early-stage breast cancer who are also receiving adjuvant hormone therapy. This clinical trial is designed to collect additional data on the safety and effectiveness of cryoablation when used as part of routine clinical care. Specifically, the study will evaluate recurrence rates following the procedure for up to 5 years post-treatment. In addition, linkage to claims data will be used to assess long-term outcomes, including breast cancer-related surgeries, mammograms and other breast imaging procedures, breast biopsies, and all-cause mortality.

Sponsor: IceCure Medical Ltd.

Who Can Participate

Inclusion Criteria

Provision of a signed and dated informed consent form.
Diagnosis of invasive ductal breast carcinoma (IDC) by core needle biopsy, meeting the following criteria:
Unifocal primary disease
Tumor size ā‰¤1.5 cm in greatest diameter
Estrogen receptor positive, Progesterone receptor positive, and HER2 negative
Low-risk tumor biology, defined as Ki67\<15% or confirmed by genomic testing. In cases where Ki67 is ā‰„15%, low-risk status must be confirmed by genomic testing, which will prevail.
Lesions must be sonographically visible at the time of treatment
Clinically negative lymph node (N0).

Exclusion Criteria

Presence of lobular carcinoma.
Presence of microinvasion or invasive breast carcinoma with extensive intraductal component (EIC), defined as DCIS component comprising ā‰„25%.
Evidence of lymphovascular invasion.
Presence of multifocal and/or multicentric breast cancer.
Presence of multifocal suspicious calcifications.
Presence of inflammatory features.
Previous ipsilateral breast radiation
Neoadjuvant endocrine treatment is provided to reduce the tumor size.
Prior or concurrent neoadjuvant chemotherapy, biological therapy, or other targeted neo-therapies.
Prior en bloc open surgical biopsy and/or lumpectomy for diagnosis/treatment of the index breast cancer.
Allergy to local anesthesia.
Any other reason defined as inoperable declared by a physician.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Germantown?

Yes, this clinical trial (NCT07629206) has an active research site in Germantown, TN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Low-Risk, Early Stage Breast Cancer Treatment Options in Germantown, TN

If you're searching for low-risk, early stage breast cancer treatment options in Germantown, TN, this clinical trial (NCT07629206) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Germantown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced low-risk, early stage breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all low-risk, early stage breast cancer clinical trials near you to find additional studies recruiting in your area.

More Breast Cancer Trials in Germantown, TN

See all breast cancer clinical trials recruiting in Germantown ā€” not just this study.

Browse Breast Cancer Trials in Germantown ā†’

Browse More Trials by Condition

Breast Cancer TrialsAnkylosing Spondylitis TrialsAll Conditions ā†’

Ready to Join in Germantown?

Take the first step toward participating in this groundbreaking clinical trial

Secure Ā· Expert Care Ā· Germantown, TN